Participants wanted :
Men and women consuming opioids and wishing to access a substitution treatment.
What is OPTIMA?:
This randomized clinical trial (NCT03033732) consisted of comparing the effectiveness of two models of care for the management of opioid use. The first is methadone treatment and the second is buprenorphine/naloxone treatment.
Your role :
- Attend follow-up visits every two weeks during 24-28 weeks
- Fill out a questionnaire
You were not admissible if:
- You have a contraindication to the medication used for this study
- You are pregnant, breastfeeding or if you plan a pregnancy during the study
- You are currently on agonist treatment (methadone or buprenorphine/naloxone)
To participate in one of our ongoing studies, please consult our directory.
To see our knowledge transfer initiatives, please consult The OPTIMA Trial.